Lisa Vermunt

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Glial Fibrillary Acidic Protein and Neurofilament Light Reference Intervals in Healthy Individuals.

Glial Fibrillary Acidic Protein and Neurofilament Light Reference Intervals in Healthy Individuals.

Journal: JAMA network open

Published: May 14, 2026

APOE and genetic risk variants influence Alzheimer's disease onset in carriers of an extra copy of APP, with and without Down syndrome.

APOE and genetic risk variants influence Alzheimer's disease onset in carriers of an extra copy of APP, with and without Down syndrome.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 10, 2026

CSF Proteomic Profiles Associated With White Matter Integrity in Cognitively Normal Older Adults With and Without Amyloid Pathology.

CSF Proteomic Profiles Associated With White Matter Integrity in Cognitively Normal Older Adults With and Without Amyloid Pathology.

Journal: Neurology

Published: March 02, 2026

Effects of the novel phosphodiesterase 9 inhibitor irsenontrine on CSF proteomics profile in Aβ+ and Aβ- dementia with Lewy bodies patients.

Effects of the novel phosphodiesterase 9 inhibitor irsenontrine on CSF proteomics profile in Aβ+ and Aβ- dementia with Lewy bodies patients.

Journal: Alzheimer's research & therapy

Published: February 05, 2026

Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias.

Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias.

Journal: Nature aging

Published: January 05, 2026

Associations of lifestyle factors with amyloid pathology in persons without dementia.

Associations of lifestyle factors with amyloid pathology in persons without dementia.

Journal: Journal of Alzheimer's disease : JAD

Published: November 14, 2025

Serial measurements of neuron specific enolase, glial fibrillary acidic protein and neurofilament light for mortality prediction in patients with severe acute brain injury in the ICU.

Serial measurements of neuron specific enolase, glial fibrillary acidic protein and neurofilament light for mortality prediction in patients with severe acute brain injury in the ICU.

Journal: Clinical chemistry and laboratory medicine

Published: October 07, 2025

Soluble SORL1 in cerebrospinal fluid as a marker for functional impact of rare SORL1 variants.

Soluble SORL1 in cerebrospinal fluid as a marker for functional impact of rare SORL1 variants.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 12, 2025

Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry-based proteomics.

Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry-based proteomics.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: August 01, 2025

Microglia protein profiles in CSF across Alzheimer's disease clinical stages.

Microglia protein profiles in CSF across Alzheimer's disease clinical stages.

Journal: Nature aging

Published: June 02, 2025

Heritability and shared environmental effects of brain diseases in 12,040 extended families.

Heritability and shared environmental effects of brain diseases in 12,040 extended families.

Journal: NPJ dementia

Published: May 06, 2025

Implications of AD plasma and PET biomarker discordance.

Implications of AD plasma and PET biomarker discordance.

Journal: Nature reviews. Neurology

Published: May 01, 2025

Showing 1-12 of 102

Last Updated: 09/26/2026